KAT6B and tumor of uterus: Whereas the range of KAT6B abnormalities and their impact on clinical and morphological UL characteristics have barely been studied, there are data suggesting that chimeric transcripts of KAT6B-KANSL1 (17q21) may be discovered in fast-growing cellular ULs, although they are most typical for malignant uterine tumours [179,180].